The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Amyloid β Protein (1−40) Forms Calcium-Permeable, Zn2+-Sensitive Channel in Reconstituted Lipid Vesicles,
Abstract
Amyloid beta protein (A beta P) forms senile plaques in the cerebrocortical blood vessels and brain parenchyma of patients with Alzheimer's disease (AD). The nonfamilial or sporadic AD (SAD), the most prevalent form of AD, has been correlated with an increased level of 40-residue A beta P (A beta P1-40). However, very little is known about the role of A beta P1-40 in AD pathophysiology. We have examined the activity of A beta P1-40 reconstituted in phospholipid vesicles. A combined light fluorescence and atomic force microscope (AFM) was used to image the structure of reconstituted vesicles and 45Ca2+ uptake was used as an assay for calcium permeability across the vesicular membrane. Vesicles reconstituted with fresh and globular A beta P1-40 contain a significant amount of A0 beta P and exhibit strong immunofluorescence labeling with an antibody raised against the N-terminal domain of A beta P, suggesting the incorporation of A beta P1-40 peptide in the vesicular membrane. Vesicles reconstituted with A beta P1-40 exhibited a significant level of 45Ca2+ uptake. The vesicular calcium level saturated over time, showing an important ion channel characteristic. The 45Ca2+ uptake was inhibited by (i) a monoclonal antibody raised against the N-terminal region of A beta P and (ii) Zn2+. However, a reducing agent (DTT) did not inhibit the 45Ca2+ uptake, indicating that the oxidation of A beta P or its surrounding lipid molecules is not directly involved in A beta P-mediated Ca2+ uptake. These findings provide biochemical and structural evidence that fresh and globular A beta P1-40 forms calcium-permeable channels and thus may induce cellular toxicity by regulating the calcium homeostasis in nonfamilial or sporadic Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of the β‐amyloid protein in Alzheimer's disease
Sisodia, S. S., & Price, D. L. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.5.7896005 · Cited by 262
Research works printed but not linked: 54
- Glenner G. G., 1984, Biochem. Biophys. Res. Commun. 120, 885−890
- Masters C. L., 1985, EMBO J., 4, 10.1002/j.1460-2075.1985.tb04000.x · DOI · Paper page
- Nashlund J., 1995, Neuron 15, 219−228
- Schendel S. L., 1997, Proc. Natl. Acad. Sci. U.S.A. 94, 5113−5118
- Antonsson B., 1997, Science 277, 370−372
- Scheuner D., 1996, 2, 864−870
- Duff K., 1996, Nature 383, 710−713
- Gandy, S. E., Caporaso, G. L., Buxmaum, J. D., De Cruz Silva, O., Iverfeldt, K., Nordstedt, C., Suzuki, T., Czernik, A. J., Nairn, A. C., and Greengard, P. (1993) Ann. N.Y. Acad. Sci. 695 , 117−121. · DOI
- Pike C. J., 1995, J. Neurochem., 64
- Price D. L., 1995, Curr. Opin. Neurol. 8, 268−274
- Yankner B. A., 1990, Science 250, 279−282
- Arispe N., 1993, Proc. Natl. Acad. Sci. U.S.A. 90, 10573−10577
- Arispe N., 1993, Proc. Natl. Acad. Sci. U.S.A. 90, 567−571
- Arispe N., 1996, Proc. Natl. Acad. Sci. U.S.A. 90, 1710−1715
- Rhee S. K., 1998, J. Biol. Chem., 273
- Zhu Y. W., 1998, Biophys. J., 74, A316
- Kosik K. S., 1992, Neurobiol. Aging 13, 535−630
- Calingasan N. Y., 1995, Brain Res., 677, 60, 10.1016/0006-8993(95)00136-E · DOI
- Benzi G., 1995, Neurobiol. Aging 16, 661−674
- Walter M. F., 1997, Biochem. Biophys. Res. Commun. 233, 760−764
- Salinero O., 1997, J. Neurosci. Res., 47, 10.1002/(SICI)1097-4547(19970115)47:2<216::AID-JNR10>3.0.CO;2-0 · DOI
- Li J., 1997, Cell 90, 917−927
- Seilheimer B., 1997, J. Struct. Biol., 119, 71, 10.1006/jsbi.1997.3859 · DOI · Paper page
- Kim T. W., 1997, Science 277, 373−376
- Ito, E., Oka, K., Etcheberrigaray, R., Nelson, T. J., Mcphie, D. L., Tofel-Grehl, B., Gibson, G. L., and Alkon, D. L. (1994) Proc. Natl. Acad. Sci. U.S.A. 91 , 534−538. · DOI · Paper page
- Mattson M. P., 1992, J. Neurosci., 12, 10.1523/JNEUROSCI.12-02-00376.1992 · DOI · Paper page
- Etcheberrigaray R., 1994, Science 264, 276−279
- Bhatia R. K., 1999, Biophys. J., 76, A206
- Kawahara M., 1997, Biophys. J., 73, 75, 10.1016/S0006-3495(97)78048-2 · DOI · Paper page
- Mason R. P., 1996, Biochem. Biophys. Res. Commun., 222, 82, 10.1006/bbrc.1996.0699 · DOI
- Durell S. R., 1994, Biophys. J., 67, 10.1016/S0006-3495(94)80717-9 · DOI · Paper page
- Mirzabekov T., 1994, Biochem. Biophys. Res. Commun. 202, 1142−1148
- Hirakura Y., 1998, Biophys. J., 74, A389
- Lal R., 1997, Int. J. Imaging Syst. Technol., 8
- Lal R., 1995, Am. J. Physiol., 269
- Anholt R., 1982, J. Biol. Chem., 257, 10.1016/S0021-9258(18)34546-0 · DOI
- Rhee S. K., 1996, Biochemistry 35, 9212−9223
- Lal R., 1993, Am. J. Physiol., 265
- Deamer D. W., 1983, in Liposomes
- Roher A. E., 1996, J. Biol. Chem., 271, 10.1074/jbc.271.34.20631 · DOI · Paper page
- Choo-Smith L.-P., 1997, J. Biol. Chem., 272
- Hass C., 1992, Nature 359, 322−325
- Seubert P., 1992, Nature 359, 325−327
- Shoji M., 1992, Science 258, 126−129
- Bush A. I., 1994, J. Biol. Chem., 269
- Bush A. I., 1994, Science 265, 1464−1467
- Garzon-Rodriguez W., 1997, J. Biol. Chem., 272, 10.1074/jbc.272.34.21037 · DOI · Paper page
- Assaf S. Y., 1984, Nature 308, 734−736
- Howell G. A., 1984, Nature 308, 736−773
- Lin M.-C., 1997, J. Biol. Chem., 272, 47
- Hirakura Y., 1999, Biophys. J., 76, A443, 10.1016/S0006-3495(99)77211-5 · doi:10.1016/s0006-3495(99)77211-5
- Kourie J. I., 1999, FEBS Lett. 445, 57−62.
- Yang A. J., 1998, J. Neurosci. Res. 52, 691−698.
- Abbreviations AβP, amyloid β protein
Cited by
The neurobiology of zinc in health and disease
Frederickson, C. J., Koh, J.-Y., & Bush, A. I. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1671 · Cited by 1,850
Amyloid ion channels: A common structural link for protein-misfolding disease
Quist, A., Doudevski, I., Lin, H., Azimova, R., Ng, D., Frangione, B., Kagan, B., Ghiso, J., & Lal, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502066102 · Cited by 982
Self-citationFunction and structure of inherently disordered proteins
Dunker, A. K., Silman, I., Uversky, V. N., & Sussman, J. L. (2008) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2008.10.002 · Cited by 963
Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology
LIN, H., BHATIA, R., & LAL, R. (2001) · The FASEB Journal · doi:10.1096/fj.01-0377com · Cited by 644
Self-citationThe redox chemistry of the Alzheimer's disease amyloid β peptide
Smith, D. G., Cappai, R., & Barnham, K. J. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.02.002 · Cited by 608
Rink, L. (2000) · Proceedings of the Nutrition Society · doi:10.1017/s0029665100000781 · Cited by 581
Chong, Z. Z., Li, F., & Maiese, K. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.02.004 · Cited by 536
Suh, Y.-H., & Checler, F. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.3.469 · Cited by 467
Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins?
Lashuel, H. A., & Lansbury, P. T. (2006) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583506004422 · Cited by 400
Two-Step Mechanism of Membrane Disruption by Aβ through Membrane Fragmentation and Pore Formation
Sciacca, M. F. M., Kotler, S. A., Brender, J. R., Chen, J., Lee, D.-K., & Ramamoorthy, A. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2012.06.045 · Cited by 362
Structural and functional imaging with carbon nanotube AFM probes
Hafner, J. H., Cheung, C.-L., Woolley, A. T., & Lieber, C. M. (2001) · Progress in Biophysics and Molecular Biology · doi:10.1016/s0079-6107(01)00011-6 · Cited by 344
Burke, K. A., Yates, E. A., & Legleiter, J. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00017 · Cited by 127
Genetic Alterations of the BRI2 gene: Familial British and Danish Dementias
J, G., A, R., Y, T., T, L., M, B.-M., H, B., G, P., J, H., R, L., T, R., et al. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2006.tb00563.x · Cited by 44
Metadata
- Authors
- Lin, H., Zhu, Y. J., & Lal, R.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1999-08-01
- Volume
- 38
- Issue
- 34
- Pages
- 11189-11196
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2067464601
- Cited by
- 159
- References
- 1
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.